These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12082548)

  • 1. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.
    Gooch JL; Christy B; Yee D
    Neoplasia; 2002; 4(4):324-31. PubMed ID: 12082548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
    Gingras S; Côté S; Simard J
    Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
    Pesu M; Takaluoma K; Aittomäki S; Lagerstedt A; Saksela K; Kovanen PE; Silvennoinen O
    Blood; 2000 Jan; 95(2):494-502. PubMed ID: 10627454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
    Murata T; Obiri NI; Puri RK
    Int J Cancer; 1997 Jan; 70(2):230-40. PubMed ID: 9009165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
    Wang HY; Zamorano J; Keegan AD
    J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation.
    Zamorano J; Kelly AE; Austrian J; Wang HY; Keegan AD
    Cell Res; 2001 Mar; 11(1):44-54. PubMed ID: 11305324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis.
    Wurster AL; Withers DJ; Uchida T; White MF; Grusby MJ
    Mol Cell Biol; 2002 Jan; 22(1):117-26. PubMed ID: 11739727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoter.
    Pesu M; Aittomäki S; Välineva T; Silvennoinen O
    Eur J Immunol; 2003 Jun; 33(6):1727-35. PubMed ID: 12778491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
    Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
    J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
    Gingras S; Moriggl R; Groner B; Simard J
    Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
    Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
    Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 mediates cell growth inhibition through activation of Stat1.
    Chang TL; Peng X; Fu XY
    J Biol Chem; 2000 Apr; 275(14):10212-7. PubMed ID: 10744706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT6 is required for the regulation of IL-4-induced cytoskeletal events in B cells.
    Davey EJ; Greicius G; Thyberg J; Severinson E
    Int Immunol; 2000 Jul; 12(7):995-1003. PubMed ID: 10882411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.
    Suzuki K; Nakajima H; Kagami S; Suto A; Ikeda K; Hirose K; Hiwasa T; Takeda K; Saito Y; Akira S; Iwamoto I
    J Exp Med; 2002 Jul; 196(1):27-38. PubMed ID: 12093868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes.
    Biola A; Andréau K; David M; Sturm M; Haake M; Bertoglio J; Pallardy M
    FEBS Lett; 2000 Dec; 487(2):229-33. PubMed ID: 11150515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts.
    Kriebel P; Patel BK; Nelson SA; Grusby MJ; LaRochelle WJ
    Oncogene; 1999 Dec; 18(51):7294-302. PubMed ID: 10602484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL; Lee AV; Yee D
    Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.